ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
Researchers discovered that the HORMAD1 gene suppresses immune response in triple-negative breast cancer by promoting PD-L1 overexpression.
The Justice Department reclassified cannabis as Schedule III, allowing FDA-approved medical marijuana research and expanded treatment options.
Read More
New Hampshire Senator Sue Prentiss introduced a bill to require Medicaid coverage for GLP-1 weight loss drugs for patients with BMI over 30.
Read More
The FDA approved the Lumipulse G pTau217/ß-Amyloid 1-42 blood test for early Alzheimer’s detection in adults 55+ with cognitive decline.
Read More
The ‘second brain’ category has been captured for a decade by note-taking apps. But once AI becomes the primary reader of the archive, the architecture has to change. The open brain is what comes next
Read More
Republican leaders on the House Energy & Commerce Committee expanded their Medicaid fraud probe by contacting officials in 10 states, including California and New York.
Read More
President Trump signed an order creating a task force led by VP J.D. Vance to combat fraud in federal health care and benefit programs.
Read More
Antiretroviral therapy reduces biological aging in HIV patients by nearly four years, showing recovery through the Proteomic Age Clock.
Read More
Novo Nordisk’s etavopivat reduced vaso-occlusive crises by 27% in Phase 3 trial for sickle cell disease; FDA approval expected in late 2026.
Read More
The AMA-backed Mental Health Parity Index tool reveals real-time insurance coverage and payment gaps for mental health across 43 states and 70% of counties.
Read More
A major U.S. hospital chain faced challenges covering GLP-1 weight loss drugs like Ozempic in employee health plans amid rising costs.
Read More
